Alaunos Therapeutics (TCRT)

• Market cap: $5.52M
• 1 day: 2.26%
• 5 days: -1.31%
• 1 month: -14.07%
• 3 months: -29.15%
• 6 months: -46.95%
• Year to date: -31.1%
• 1 year: -24.67%
• 5 years: -99.49%
• 10 years: -99.76%
• Sector: Healthcare
• Industry: Biotechnology

About: Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Employees: 1